Effects of Aerobic Exercise on Lean Non-alcoholic Fatty Liver Disease (NAFLD)
1 other identifier
interventional
100
1 country
1
Brief Summary
NAFLD is increasingly being identified in lean individuals, especially in Chinese population. Among the NAFLD patients, the lean NAFLD accounts for 15.9%-23.0%. Previous studies showed that the lean NAFLD individuals might have a higher risk of severe hepatic disease than those obese individuals. However, the effects of aerobic exercise on the reduction of liver fat content and metabolic risk factors in lean NAFLD individuals remain unknown. In this randomized controlled trial, we will examine the effect of a 3-month exercise training (aerobic exercise) on liver fat content and metabolic risk factors in lean NAFLD individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 28, 2021
CompletedFirst Posted
Study publicly available on registry
May 12, 2021
CompletedStudy Start
First participant enrolled
May 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2022
CompletedSeptember 20, 2024
September 1, 2024
1.4 years
April 28, 2021
September 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes from baseline in the liver fat content at 3 months after intervention.
The magnetic resonance imaging-derived proton density fat fraction (MRI-PDFF) is used to detect the liver content. An diagnosis of NAFLD is the liver fat content \> 5%. Changes = (liver fat content at 3 months after intervention - liver fat content at baseline)
3 months
Secondary Outcomes (12)
Changes from baseline in body mass index (BMI) at 3/12 months after intervention.
3 months, 12 months
Changes from baseline in waist hip ratio(WHR) at 3/12 months after intervention.
3 months, 12 months
Changes from baseline in abdominal fat at 3/12 months after intervention.
3 months, 12 months
Changes from baseline in blood pressure at 3/12 months after intervention.
3 months, 12 months
Changes from baseline in triglycerides at 3/12 months after intervention.
3 months, 12 months
- +7 more secondary outcomes
Study Arms (2)
Aerobic Exercise Intervention Group
EXPERIMENTALThe subjects receive an intensive aerobic exercise for 3 months and a health education content for 12 months.
Control Group
NO INTERVENTIONThe subjects do not change their physical activity routine and receive a health education content for 12 months.
Interventions
The subjects conduct an aerobic exercise at 65-80% maximum oxygen consumption three times per week for 60 min/session (including 5 min warm-up and 5 min cool down) with treadmills, ellipticals, and rowing machine. The subjects attend health education sessions (eg, general health knowledge of NAFLD and metabolic diseases, and elements of a healthy lifestyle) monthly in the 12 months.
Eligibility Criteria
You may qualify if:
- \. Subjects with NAFLD determined by MRI-PDFF (liver fat\>5%).
- \. Subjects with BMI\<23 kg/m2.
- \. Subjects with inactive exercise before.
- \. Subjects with basic abilities of understanding, communication and writing.
You may not qualify if:
- \. Regular drinkers (consumed more than an average of 140 grams of ethanol per week in men and 70 grams in women during the past twelve months).
- \. Complicated with other liver diseases (i.e. acute or chronic viral hepatitis, liver cancer, liver cirrhosis, drug-induced liver diseases, and autoimmune hepatitis).
- \. Subjects with abnormal liver function (i.e. more than 3 times the upper limit of normal alanine aminotransferase and aspartate aminotransferase).
- \. Complicated with severe cardiovascular disease \[i.e. myocardial infarction, arrhythmia, heart failure (New York Heart Association III or IV), uncontrolled hypertension (i.e. systolic blood pressure \>180 mmHg, and/or diastolic blood pressure \>100 mmHg)\].
- \. Complicated with severe kidney disease or severe renal insufficiency or tumour.
- \. Currently pregnant or planning to be pregnant or breast feeding women.
- \. Participating in weight loss programs/exercise programs currently or during the past three months.
- \. Having any medical condition that would affect metabolism or limit exercise (i.e. diabetes, known hyperthyroidism or hypothyroidism).
- \. Having a medical condition that would limit exercise participation or alter heart rate during exercise or taking medication that would affect metabolism or weight loss (i.e. glucocorticoids, antithyroid drugs, hypoglycemic drugs, antihypertensive drugs).
- \. Having been doing regular physical exercise for the past three months (i.e. 3 times/week, \>30 min/time).
- \. Subjects with poor adherence.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The First Affiliated Hospital with Nanjing Medical University
Nanjing, China, 210029, China
Related Publications (4)
Lee S, Bacha F, Hannon T, Kuk JL, Boesch C, Arslanian S. Effects of aerobic versus resistance exercise without caloric restriction on abdominal fat, intrahepatic lipid, and insulin sensitivity in obese adolescent boys: a randomized, controlled trial. Diabetes. 2012 Nov;61(11):2787-95. doi: 10.2337/db12-0214. Epub 2012 Jun 29.
PMID: 22751691BACKGROUNDZhang HJ, He J, Pan LL, Ma ZM, Han CK, Chen CS, Chen Z, Han HW, Chen S, Sun Q, Zhang JF, Li ZB, Yang SY, Li XJ, Li XY. Effects of Moderate and Vigorous Exercise on Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial. JAMA Intern Med. 2016 Aug 1;176(8):1074-82. doi: 10.1001/jamainternmed.2016.3202.
PMID: 27379904BACKGROUNDHoughton D, Thoma C, Hallsworth K, Cassidy S, Hardy T, Burt AD, Tiniakos D, Hollingsworth KG, Taylor R, Day CP, McPherson S, Anstee QM, Trenell MI. Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2017 Jan;15(1):96-102.e3. doi: 10.1016/j.cgh.2016.07.031. Epub 2016 Aug 10.
PMID: 27521509BACKGROUNDKistler KD, Brunt EM, Clark JM, Diehl AM, Sallis JF, Schwimmer JB; NASH CRN Research Group. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am J Gastroenterol. 2011 Mar;106(3):460-8; quiz 469. doi: 10.1038/ajg.2010.488. Epub 2011 Jan 4.
PMID: 21206486BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Qun Zhang, Professor
The First Affiliated Hospital with Nanjing Medical University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 28, 2021
First Posted
May 12, 2021
Study Start
May 14, 2021
Primary Completion
September 30, 2022
Study Completion
September 30, 2022
Last Updated
September 20, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share